T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease

[1]  R. Mailman,et al.  Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes , 2018, Movement disorders : official journal of the Movement Disorder Society.

[2]  Wei Zhou,et al.  Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping , 2018, Journal of the Neurological Sciences.

[3]  Tatia M.C. Lee,et al.  White matter microstructural abnormalities in amnestic mild cognitive impairment: A meta-analysis of whole-brain and ROI-based studies , 2017, Neuroscience & Biobehavioral Reviews.

[4]  A. Kypraiou,et al.  Iron in neurodegenerative disorders: being in the wrong place at the wrong time? , 2017, Reviews in the neurosciences.

[5]  Xiaojun Xu,et al.  Region-Specific Iron Measured by MRI as a Biomarker for Parkinson’s Disease , 2017, Neuroscience Bulletin.

[6]  Jingjing Xu,et al.  Influence of regional iron on the motor impairments of Parkinson's disease: A quantitative susceptibility mapping study , 2017, Journal of magnetic resonance imaging : JMRI.

[7]  Marios Politis,et al.  Cognitive decline in Parkinson disease , 2017, Nature Reviews Neurology.

[8]  Chunlei Liu,et al.  Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping , 2017, NMR in biomedicine.

[9]  D. Brooks,et al.  Imaging synucleinopathies , 2016, Movement disorders : official journal of the Movement Disorder Society.

[10]  I. Deary,et al.  Do white matter hyperintensities mediate the association between brain iron deposition and cognitive abilities in older people? , 2016, European journal of neurology.

[11]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[12]  Michael Schocke,et al.  Dorsolateral nigral hyperintensity on 3.0T susceptibility‐weighted imaging in neurodegenerative Parkinsonism , 2015, Movement disorders : official journal of the Movement Disorder Society.

[13]  E Mark Haacke,et al.  Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. , 2015, Magnetic resonance imaging.

[14]  J. Connor,et al.  A Novel Model for Brain Iron Uptake: Introducing the Concept of Regulation , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  Cyril Poupon,et al.  7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[16]  Jeff H Duyn,et al.  The role of iron in brain ageing and neurodegenerative disorders , 2014, The Lancet Neurology.

[17]  Klaus P. Ebmeier,et al.  Predictors of cognitive impairment in an early stage Parkinson’s disease cohort , 2014, Movement disorders : official journal of the Movement Disorder Society.

[18]  Maija E. Rossi,et al.  Clinical MRI for iron detection in Parkinson's disease. , 2013, Clinical imaging.

[19]  C. Caltagirone,et al.  Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population , 2013, Neurological Sciences.

[20]  H. Mochizuki,et al.  Iron accumulation in Parkinson’s disease , 2012, Journal of Neural Transmission.

[21]  Joanna M. Wardlaw,et al.  Brain iron deposits are associated with general cognitive ability and cognitive aging , 2012, Neurobiology of Aging.

[22]  R. Barker,et al.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines , 2012, Movement disorders : official journal of the Movement Disorder Society.

[23]  E M Haacke,et al.  Different Iron-Deposition Patterns of Multiple System Atrophy with Predominant Parkinsonism and Idiopathetic Parkinson Diseases Demonstrated by Phase-Corrected Susceptibility-Weighted Imaging , 2012, American Journal of Neuroradiology.

[24]  M. Freedman,et al.  Italian norms for the Freedman version of the Clock Drawing Test , 2011, Journal of clinical and experimental neuropsychology.

[25]  P Eusebi,et al.  A magnetization transfer study of mild and advanced Parkinson’s disease , 2011, European journal of neurology.

[26]  A. Stefani,et al.  Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. , 2010, Brain : a journal of neurology.

[27]  Jian Wang,et al.  Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: An in vivo MR study , 2010, Brain Research.

[28]  Y. Wu,et al.  Determination of brain iron content in patients with Parkinson’s disease using magnetic susceptibility imaging , 2009, Neuroscience bulletin.

[29]  G. Anderson,et al.  Iron absorption and metabolism , 2009, Current opinion in gastroenterology.

[30]  E. Haacke,et al.  Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1 , 2008, American Journal of Neuroradiology.

[31]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[32]  M. Paley,et al.  MRI assessment of basal ganglia iron deposition in Parkinson's disease , 2008, Journal of magnetic resonance imaging : JMRI.

[33]  B. Ravina,et al.  The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[34]  Marguerite Wieler,et al.  Midbrain iron content in early Parkinson disease , 2008, Neurology.

[35]  Carlo Ciulla,et al.  Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain , 2007, Journal of magnetic resonance imaging : JMRI.

[36]  B. Schmand,et al.  Cognitive profile of patients with newly diagnosed Parkinson disease , 2005, Neurology.

[37]  R. Gentleman,et al.  Classification Using Generalized Partial Least Squares , 2005 .

[38]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[39]  W. Poewe,et al.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[40]  M. Tovée,et al.  Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia , 2004, International journal of geriatric psychiatry.

[41]  G. Bartzokis,et al.  Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases , 2004 .

[42]  Ya Ke,et al.  Iron misregulation in the brain: a primary cause of neurodegenerative disorders , 2003, The Lancet Neurology.

[43]  C. Caltagirone,et al.  Different Components in Word-List Forgetting of Pure Amnesics, Degenerative Demented and Healthy Subjects , 1995, Cortex.

[44]  E Capitani,et al.  A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[45]  R. Ordidge,et al.  Assessment of relative brain iron concentrations using T2‐weighted and T2*‐weighted MRI at 3 Tesla , 1994, Magnetic resonance in medicine.

[46]  Marcella Laiacona,et al.  Tre test clinici di ricerca e produzione lessicale , 1986 .

[47]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[48]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[49]  S. Katz,et al.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.

[50]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[51]  Maija E. Rossi,et al.  Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages. , 2014, Academic radiology.

[52]  C. Zhong,et al.  Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. , 2011, Brain : a journal of neurology.

[53]  D. Wechsler,et al.  Wechsler Adult Intelligence Scale—Fourth Edition (WAIS-IV) , 2010 .

[54]  M. Kuhn.  The caret Package , 2007 .

[55]  C. Caltagirone,et al.  The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. , 1996, European neurology.